J. Duato, also known as Joaquin Duato, is the Chairman and Chief Executive Officer of Johnson & Johnson, a leading multinational corporation in the pharmaceutical and consumer goods industries. Born in Spain, Duato joined Johnson & Johnson in 1989 and has held various leadership positions within the company over the years. His career trajectory showcases a deep commitment to the company's mission of improving health and well-being worldwide. Before ascending to the role of Chairman and CEO in 2022, Duato served as the company's Executive Vice President and Worldwide Chairman of Pharmaceuticals. In this capacity, he played a pivotal role in driving the growth and innovation of Johnson & Johnson's pharmaceutical division. Under his leadership, the company successfully developed and launched several groundbreaking treatments, solidifying its position as a leader in the global healthcare industry. Duato's strategic vision and dedication to advancing medical science have been instrumental in shaping Johnson & Johnson's success. As Chairman and CEO, Duato is responsible for overseeing the overall strategy and operations of Johnson & Johnson. He leads a diverse team of professionals across the company's various sectors, including pharmaceuticals, medical devices, and consumer health products. Duato's leadership style emphasizes collaboration, innovation, and a patient-centric approach. He is committed to fostering a culture of inclusivity and excellence within the organization, while also working to expand access to healthcare solutions on a global scale. Under his guidance, Johnson & Johnson continues to innovate and adapt to the evolving needs of patients and consumers worldwide.